Connor, Clark & Lunn Investment Management (CC&L)
JANX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Janux Therapeutics JANX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio JANX Stock Details JANX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,892
Closed -$259K – 1528
2024
Q1 		$259K Sell
6,892
-5,924
-46% -$223K ﹤0.01% 1320
2023
Q4 		$138K Buy
+12,816
New +$138K ﹤0.01% 1298